Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Mirella Saliola"'
Autor:
Daniele Pastori, Danilo Menichelli, Francesco Del Sole, Marco De Russis, Marco Antonio Casciaro, Francesco Violi, Mirella Saliola, Roberto Carnevale, Pasquale Pignatelli
Publikováno v:
Mayo Clinic Proceedings. 96:658-665
To determine the association between direct oral anticoagulant (DOAC) use and risk of major adverse cardiac events (MACEs) in patients with atrial fibrillation (AF).This study is a single-center prospective observational cohort study including 2366 o
Autor:
Martina Berteotti, Marco Antonio Casciaro, Daniele Pastori, Gregory Y.H. Lip, Francesco Violi, Vito Menafra, Evaristo Ettorre, Mirella Saliola, Cosmo Godino, Francesco Melillo, Francesco Perticone, Pasquale Pignatelli, Rossella Marcucci, Danilo Menichelli, Angela Sciacqua
Publikováno v:
Br J Clin Pharmacol
AIMS: To investigate the decline of estimated glomerular filtration rate (eGFR) in patients with atrial fibrillation (AF) treated with vitamin K antagonists (VKAs) or non‐VKA oral anticoagulants (NOACs). METHODS: Multicentre prospective cohort stud
Autor:
Emilia Antonucci, Gualtiero Palareti, Gregory Y.H. Lip, Daniele Pastori, Mirella Saliola, Pasquale Pignatelli, Francesco Violi, Luca Rubino, Danilo Menichelli, Daniela Poli
Publikováno v:
Pastori, D, Lip, G Y H, Poli, D, Antonucci, E, Rubino, L, Menichelli, D, Saliola, M, Violi, F, Palareti, G, Pignatelli, P & Italian Federation of Anticoagulation Clinics (FCSA) 2020, ' Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study ', British Journal of Haematology, vol. 190, no. 4, pp. 588-593 . https://doi.org/10.1111/bjh.16528
Quality of warfarin therapy in patients with a mechanical prosthetic heart valve (MPHV) has been barely investigated. We analysed determinants of low time in the therapeutic range (TiTR
Autor:
Daniele Pastori, Danilo Menichelli, Gregory Y.H. Lip, Angela Sciacqua, Francesco Violi, Pasquale Pignatelli, Mirella Saliola, Marco Antonio Casciaro, Greta Rende, Tommasa Vicario, Francesco Del Sole, Tommaso Bucci
Publikováno v:
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY
Background: To investigate the association between family history of atrial fibrillation (AF) with cardiovascular events (CVEs), major adverse cardiac events (MACE), and cardiovascular mortality. Methods: Multicenter prospective observational cohort
Autor:
Daniele Pastori, Francesco Angelico, Claudia Iannilli, Elio Sabbatini, Francesco Violi, Maria Del Ben, Alessio Farcomeni, Marco Antonio Casciaro, Mirella Saliola, Maria Santulli, Pasquale Pignatelli, Cristina Nocella, Angela Sciacqua, Patrizia Iannucci, Rossella Marcucci, Francesco Perticone, Fortunata Vasaturo, Simona Bartimoccia, Francesco Baratta, Roberto Carnevale, Tiziana Di Stefano, Vittoria Cammisotto
Objective To estimate the prevalence of nonalcoholic fatty liver disease (NAFLD) and its impact on bleeding and thrombotic events in patients with atrial fibrillation (AF). Patients and Methods Prospective multicenter cohort study including patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1a351c0e44b8f8b15171c9a1aa1d3b6
http://hdl.handle.net/2108/253087
http://hdl.handle.net/2108/253087
Autor:
Daniele Pastori, Cristina Nocella, Alessio Farcomeni, Simona Bartimoccia, Maria Santulli, Fortunata Vasaturo, Roberto Carnevale, Danilo Menichelli, Francesco Violi, Pasquale Pignatelli, Mirella Saliola, Marco Antonio Casciaro, Domenico Ferro, Tommasa Vicario, Fabiana Albanese, Francesco Cribari, Alberto Paladino, Francesco Del Sole, Marta Novo, Vittoria Cammisotto, Paola Andreozzi, Tiziana Di Stefano, Patrizia Iannucci, Elio Sabbatini
Publikováno v:
Journal of the American College of Cardiology. 70:1455-1462
Background: Soluble proprotein convertase subtilisin/kexin type 9 (PCSK9) has been shown to be predictive of cardiovascular events (CVEs) in patients who are at high cardiovascular risk. No...
Autor:
Danilo Menichelli, Evaristo Ettorre, Elisabetta Del Sordo, Daniele Pastori, Cinzia Marchese, Marco Antonio Casciaro, Mirella Saliola, Pasquale Pignatelli, Maria Santulli, Vittoria Cammisotto, Fortunata Vasaturo, Francesco Violi, Alessio Farcomeni, Luca Rubino, Roberto Carnevale, Simona Bartimoccia, Cristina Nocella, Valentina Castellani
Background and aims Lipopolysaccharides (LPS) is emerging as a novel risk factor for cardiovascular events (CVEs). Furthermore, in vitro evidence suggested that LPS may elicit proprotein convertase subtilisin/kexin 9 (PCSK9) expression, but their rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b798a79e8bfa184d06e3685bce53b731
http://hdl.handle.net/11573/1310453
http://hdl.handle.net/11573/1310453
Autor:
Francesca Violi, Francesco Cribari, Pasquale Pignatelli, Mirella Saliola, Daniele Pastori, Gregory Y.H. Lip, Roberto Carnevale
Publikováno v:
Pastori, D, Pignatelli, P, Cribari, F, Carnevale, R, Saliola, M, Violi, F & Lip, G Y H 2018, ' Time to therapeutic range (TtTR), anticoagulation control, and cardiovascular events in vitamin K antagonists–naive patients with atrial fibrillation ', American Heart Journal, vol. 200, pp. 32-36 . https://doi.org/10.1016/j.ahj.2018.03.004
Background: Vitamin K antagonists (VKAs) reduce cardiovascular events (CVEs) in atrial fibrillation (AF) when a time in therapeutic range (TiTR) >70% is achieved. Factors affecting the time to achieve the TR (TtTR) are unknown. Methods: Prospective o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2104acc8adade6a002501f3af6bb4788
https://vbn.aau.dk/ws/files/320294684/Pastori_et_al_Time_to_therapeutic_range_AHJ_2018.pdf
https://vbn.aau.dk/ws/files/320294684/Pastori_et_al_Time_to_therapeutic_range_AHJ_2018.pdf
Autor:
Elio Sabbatini, Daniele Pastori, Claudia Iannilli, Tiziana Di Stefano, Francesco Violi, Mirella Saliola, Danilo Menichelli, Fabiana Albanese, Pasquale Pignatelli, Francesco Del Sole, Gregory Y.H. Lip, Domenico Ferro, Roberto Carnevale, Marco Antonio Casciaro, Patrizia Iannucci, Alessio Farcomeni
Publikováno v:
Pastori, D, Farcomeni, A, Saliola, M, Del Sole, F, Pignatelli, P, Violi, F, Lip, G Y H & ATHERO-AF Study Group 2018, ' Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation ', European Journal of Internal Medicine, vol. 54, pp. 34-39 . https://doi.org/10.1016/j.ejim.2018.04.007
BACKGROUND: Optimal time in therapeutic range (TTR) of vitamin K antagonists (VKAs) is crucial for cardiovascular events (CVEs) prevention in non-valvular atrial fibrillation (NVAF). The relationship between temporal changes of TTR and the incidence
Autor:
Daniele Pastori, Gregory Y.H. Lip, Alessio Farcomeni, Francesco Del Sole, Angela Sciacqua, Francesco Perticone, Rossella Marcucci, Elisa Grifoni, Pasquale Pignatelli, Francesco Violi, Mirella Saliola, Marco Antonio Casciaro, Danilo Menichelli, Francesco Cribari, Alberto Paladino, Rony Gingis, Marta Novo, Vittoria Cammisotto, Cristina Nocella, Simona Bartimoccia, Roberto Carnevale, Tiziana Di Stefano, Patrizia Iannucci, Elio Sabbatini, Luigi Anastasio, Joseph Tassone Eliezer
Publikováno v:
Data in Brief
Data in Brief, Vol 17, Iss, Pp 830-836 (2018)
Data in Brief, Vol 17, Iss, Pp 830-836 (2018)
This article contains the data showing the different characteristics of atrial fibrillation (AF) patients treated with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) screened for the presence of liver fibrosis (LF) and follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b15fbc85ca998722f68f0d3341ede7e
http://hdl.handle.net/11573/1086960
http://hdl.handle.net/11573/1086960